The discovery of RWJ-54428 (MC-02,479), a new cephalosporin displaying promising activity against sensitive and resistant Gram-positive bacteria, is described. Progressive structural modification from the previously reported 3-phenylthiocephem MC-02,33 1 afforded an overall increase in potency against MRSAwhile retaining other key properties such as acceptable solubility and serum binding. Evaluation of the in vitro potency and in vivo efficacy of a series of closely related compounds resulted in selection of RWJ-54428(MC-02,479) for further studies.
In response to the increasing incidence of infections due to multi-resistant Gram-positive pathogens in the nosocomial environment, a research program was initiated to find novel agents to combat methicillin-resistant staphylococci (MRS), vancomycin-and ampicillin-resistant enterococci, and penicillin-resistant pneumococci. The discovery of MC-02,331, a new cephalosporin antibiotic whose potent activity against MRS is attributable to its substantially higher affinity for PBP2a (the penicillinbinding protein responsible for methicillin resistance in staphylococci), has been previously described. 1} While MC-02,331 represented an important advance in the program, further improvement in potency against MRSwas desired.
This article describes a series of successive structural modifications, resulting in identification of (MC-02,479) as a compoundworthy of further evaluation as a potential drug candidate.
Materials and Methods

Synthesis
The methods described herein for preparation of RWJ- 
To a solution of 7-amino-3-chlorocephalosporanic acid diphenylmethyl ester toluenesulfonic acid salt (5.0 g, 8.72 mmol) in dry THFat room temperature (100 ml) was added pyridine (0.63 g, 10.0mmol), followed by (Z)-2-(2-amino- 
and anisole (1.0ml) was added trifluoroacetic acid (13ml).
After 1.5 hours, the reaction mixture was concentrated under vacuumat roomtemperature, and the oily residue was dissolved in 98% formic acid (20ml). After 4 hours at room temperature, formic acid was removed under vacuum, and the residue was dissolved in water (25ml). The insoluble material was removed by centrifugation. The supernatant was purified on an HP20 column by elution with water, then 0.1 m aqueous ammoniumacetate, then finally eluting the product with 1 : 4 acetonitrile/water. The eluate was concentrated to about 1/10 original volume, and the resulting precipitate was filtered, washed with water and dried in vacuum to yield zwitterionic product (260 mg). The methanesulfonate salt was prepared by suspending the above material in water (15ml) followed by addition of methanesulfonic acid (1.0m in water, 0.98eq) and acetonitrile (5ml). After evaporation of the resulting solution to dryness, the residue was dissolved in water (30 ml) and centrifuged to remove insoluble material, and the supernatant was lyophilized to produce the title compound MICDetermination: Susceptibility tests were performed using a broth microdilution assay according to NCCLS reference methods4-* with minor modifications. Assays were performed in a final volume of 100 ji\ using Mueller-Hinton broth (Difco). The bacterial inocula were adjusted to yield a density of 5X l05CFU/ml. Antibiotics were prepared at a concentration equivalent to 2-fold the highest desired final concentration in culture medium.Antibiotics were then diluted directly in the 96-well microtiter plates by serial 2-fold dilution using a multichannel pipette. Microtiter plates were incubated during 24 hours at 35°C and were read 
Results and Discussion
The original design of MC-02,331 was based on the recognition that two positive charges would be required within the molecule in order for both protein binding and solubility to be within an acceptable range.1} Further, these charges would have to reside within the C(3)-substituent in order to allow use of the widely accepted neutral aminothiazolyl(oximino)acetyl-type substituent at the 7-position. Earlier work by our groups and by others7~9) had established the importance of a lipophilic group at the 3-position for high affinity to PBP2a. Based on a hypothesis that the existence of two charged groups at the 3-position of MC-02,331was detrimental to its activity, a means was 1275 sought to accomplish the seemingly contradictory task of maintaining the solubilizing effect of the second charge while diminishing its impact on lipophilicity. One attractive approach to accomplishing this was to replace the 4-(isothiouroniummethyl)phenyl moiety by a 4-pyridyl group, which would be protonated at acidic pH to afford solubility for administration, but would be uncharged at physiological pH. This analog (1) was prepared, and its methanesulfonate salt demonstrated aqueous solubility of >20mg/ml. However, its antibacterial potency was somewhat disappointing ( Table 1) .
Encouraged by the ability to form a soluble salt of compound 1, a program of modification of the positivelycharged moiety appended to the pyridylthio group at C(3) was initiated. Selected analogs are shown in Figure 2 . The biological results on this series of compounds ( Table 1 ) show clearly that an unsubstituted aminoethylthiomethyl Table 1 . In vitro and in vivo activity ofpyridylthio analogs ofMC-02,331.
(See Fig. 2 The substituents attached to the C(3)-pyridylthio group shown in Figure 4 explore a variety of spacer lengths, linking groups, substituent effects, and positively-charged groups. While a few compoundsdisplay potency equivalent to that of 14, the majority are less potent either in vitro or in vivo (Table 3 ). The changes in activity in response to alkyl, substitution and incorporation of polar groups are similar to those described above for the compounds in Table 1 . As with compound 1, the methanesulfonate salt of 14 demonstrated aqueous solubility of >20mg/ml. As a result of these observations, larger quantites of 14 (MC-02,479, RWJ-54428) were prepared in order to permit further microbiological and pharmacological evaluation. The synthesis of RWJ-54428 (MC-02,479) is shown in Figure 5 . In summary, replacement of the 2 ,4-bis(isothiouroniummethyl)phenylthio moiety of MC-02,3 3 1 with a 3-(aminoethylthiomethyl)-4-pyridylthio moiety, and concomitant chlorine substitution on the aminothiazole ring at the 7-position, resulted in a significant improvement in in 
